Dilatation, Pathologic: Clinical Trials

2 trials for Dilatation, Pathologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intrauterine Lidocaine for Laminaria
Lidocaine, Normal Saline - Abortion, Induced, Pain Management
Phase 1CompletedUniversity of North Carolina, Chapel Hill722012-09-012014-05-14
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
SMS995, Placebo - Irritable Bowel Syndrome (IBS)
Phase 1CompletedNovartis502008-01-012009-05-08

Narrower conditions

Agnosia (1)  ·  Irritable Bowel Syndrome (1)  ·  Syndrome (1)

Broader conditions

Pathological Conditions, Anatomical (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Digestive System Diseases (1)  ·  Disease (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Perceptual Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Lidocaine (1)  ·  Octreotide (1)  ·  Saline Solution (1)

Sponsors

Novartis (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (2)  ·  Canada (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Rebecca J Mercier, MD MPH (1)

Results publications

PMID 25139724